您的位置：
首页
>
农业专利
>
详情页
DYRK1 INHIBITORS AND USES THEREOF
专利权人:
Bertrand Leblond
发明人:
Bertrand Leblond,Anne-Sophie Casagrande,Laurent Desire,Alicia Foucourt,Thierry Besson
申请号：
US14238925
公开号：
US20140275064A1
申请日:
2012.08.17
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The present invention relates to novel thiazolo[5,4-f]quinazoline compounds and methods that are useful in the amelioration, treatment or control of Downs syndrome or early Alzheimers disease or in the amelioration, treatment or control of cancers, especially solid tumors. More specifically, the invention relates to DYRK1A and/or DYRK1B inhibitors and to methods for preparing such compounds.
来源网站：
中国工程科技知识中心
来源网址：
http://www.ckcest.cn/home/
相关专利
DYRK1 INHIBITORS AND USES THEREOF
DYRK1 DYRK1 INHIBITORS AND USES THEREOF
IMMUNOGENIC PEPTIDES FOR USE IN THE PREVENTION AND/OR TREATMENT OF INFECTIOUS DISEASES, AUTOIMMUNE DISEASES, IMMUNE RESPONSES TO ALLOFACTORS, ALLERGIC DISEASES, TUMORS, GRAFT REJECTION AND IMMUNE RESPONSES AGAINST VIRAL VECTORS USED FOR GENE THERAPY OR GENE VACCINATION
IMMUNOGENIC PEPTIDES FOR USE IN THE PREVENTION AND/OR TREATMENT OF INFECTIOUS DISEASES AUTOIMMUNE DISEASES IMMUNE RESPONSES TO ALLOFACTORS ALLERGIC DISEASES TUMORS GRAFT REJECTION AND IMMUNE RESPONSES AGAINST VIRAL VECTORS USED FOR GENE THERAPY OR GENE VACCINATION
Immunogenic peptides for use in the prevention and / or treatment of infectious diseases, autoimmune diseases, immune responses to allopaths, allergic diseases, tumors, graft rejection, and immune responses against viral vectors used for gene therapy or gene vaccination.
